Cytokinetics (CYTK) Misses Q1 EPS by 18c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $82.19 +1.72%
Revenue Growth %: -75.4%
Financial Fact:
Research and development, grant and other revenues: 441K
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: -75.4%
Financial Fact:
Research and development, grant and other revenues: 441K
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q1 EPS of ($1.38), $0.18 worse than the analyst estimate of ($1.20). Revenue for the quarter came in at $4.61 million versus the consensus estimate of $2.1 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Darden Restaurants (DRI) PT Raised to $240 at UBS as Stock Remains a 'Quality Compounder'
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
